+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Enzyme-Linked Immunosorbent Assay Service Market - Global Forecast 2026-2032- Product Image
Enzyme-Linked Immunosorbent Assay Service Market - Global Forecast 2026-2032- Product Image
Sale

Enzyme-Linked Immunosorbent Assay Service Market - Global Forecast 2026-2032

  • Report

  • 193 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6118477
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Enzyme-Linked Immunosorbent Assay Service Market is projected to reach USD 1.87 Billion in 2026. It is expected to continue growing at a CAGR of 7.79%, reaching USD 2.95 Billion by 2032.

ELISA Services Support Broad, Standardized Biomarker Testing

Enzyme-linked immunosorbent assay (ELISA) services provide outsourced testing for detecting and quantifying proteins, antibodies, hormones, antigens, and other analytes. Demand is supported by pharmaceutical and biotechnology research, clinical development, diagnostics, food safety, environmental monitoring, and academic studies. Service value is shaped by assay validation, sample handling, sensitivity, specificity, turnaround time, regulatory documentation, and the ability to customize protocols for complex matrices.

Outsourcing Is Shifting Toward Integrated, Quality-Centric Workflows

The service landscape is evolving from isolated plate-based testing toward integrated workflows that combine assay development, sample preparation, validation, data interpretation, and regulated reporting. Customers increasingly prioritize reproducibility across laboratories, transparent quality controls, electronic data records, and fit-for-purpose validation. Multiplexing, automation, smaller sample volumes, and compatibility with difficult biological matrices are also influencing procurement decisions, while tighter biosafety and data-integrity expectations raise the importance of documented procedures and qualified personnel.

Artificial Intelligence Strengthens Assay Design, Quality Control, and Interpretation

Artificial intelligence is contributing to ELISA services mainly through workflow optimization rather than replacing laboratory execution. Machine-learning tools can help identify anomalous wells, distinguish signal from background, optimize dilution schemes, support curve fitting, and flag potential plate effects. Natural-language systems can assist with protocol documentation and report preparation, while predictive analytics may improve sample triage and scheduling. Effective adoption still depends on representative training data, human review, validated algorithms, cybersecurity, and clear audit trails, particularly in regulated studies.

Regional Conditions Differ Across Infrastructure, Regulation, and Research Demand

North America benefits from mature pharmaceutical, biotechnology, academic, and contract-research ecosystems, with strong emphasis on validation, electronic records, and regulated bioanalysis. Europe combines advanced research capacity with detailed quality and data-protection expectations across the European Union and neighboring markets. Asia-Pacific is supported by expanding biomedical research, manufacturing, and diagnostics capabilities, although service consistency and regulatory alignment vary by country. Latin America shows opportunities linked to public-health research, agriculture, and infectious-disease testing, while laboratory access and import logistics can be uneven. The Middle East is investing in healthcare and life-science infrastructure, with demand concentrated around specialized centers. Africa’s requirements are closely connected to infectious-disease surveillance, public-health programs, food testing, and strengthening laboratory networks.

Economic and Security Alliances Shape Cross-Border Testing Requirements

ASEAN economies are building stronger regional research and healthcare linkages, creating demand for standardized protocols and dependable sample logistics. BRICS members span large and diverse research systems, making harmonized quality practices and local technical capacity important. The European Union emphasizes common regulatory principles, traceability, and data governance. G7 countries generally maintain advanced research and quality infrastructures, while their procurement environments favor documented performance and robust compliance. GCC members are expanding healthcare and laboratory capabilities, with central priorities including specialized expertise and supply-chain resilience. NATO countries may require dependable testing support for biomedical research, preparedness, and public-health collaboration, subject to national rules and security considerations.

National Capabilities Reflect Distinct Research and Regulatory Priorities

The United States and Canada have mature research and contract-testing environments with strong validation expectations. Germany, France, Italy, Spain, and the United Kingdom combine established biomedical research with detailed quality and data-governance requirements. Australia supports applications across medical research, agriculture, and environmental testing. China, Japan, South Korea, and India are strengthening domestic laboratory, biopharmaceutical, and diagnostics capabilities while emphasizing process consistency and technical expertise. Brazil and Mexico serve diverse research and public-health needs, with logistics, infrastructure, and regulatory coordination influencing service delivery. Russia maintains demand across academic, industrial, and public-sector applications, while access to international inputs and cross-border collaboration can affect workflow planning.

Leaders Should Build Resilient, Validated, and Digitally Traceable Service Models

Industry leaders should segment services by research, clinical, diagnostic, food, and environmental use cases, then define fit-for-purpose validation requirements for each. They should invest in automation where it improves repeatability, maintain orthogonal quality controls, and document acceptance criteria before testing begins. Regional delivery models should account for sample stability, import rules, biosafety, language, and data residency. AI tools should be introduced under formal validation and human oversight. Finally, leaders should strengthen continuity planning through qualified suppliers, redundant instruments, secure data systems, transparent turnaround commitments, and regular review of assay performance.

Methodology Combines Market-Specific Scope With Evidence-Based Service Analysis

This executive summary uses the defined scope of enzyme-linked immunosorbent assay services and evaluates the field through established service characteristics: applications, workflow requirements, quality systems, technology adoption, regulatory considerations, and geographic operating conditions. Regional, group, and country comparisons are framed around observable differences in research infrastructure, healthcare capacity, laboratory maturity, logistics, and compliance expectations. The assessment is qualitative and deliberately excludes market estimates, market shares, forecasts, and unsupported company-level claims. Interpretations should be validated against current regulatory guidance, laboratory standards, procurement records, and primary stakeholder interviews before operational decisions are made.

Reliable ELISA Services Depend on Quality, Integration, and Regional Adaptability

ELISA services remain relevant because they offer a flexible and widely understood approach to biomarker and analyte measurement across research, healthcare, industrial, and public-sector settings. Competitive differentiation increasingly rests on validated performance, efficient workflows, data integrity, specialized expertise, and dependable global delivery rather than testing alone. Providers and buyers that combine scientific rigor with automation, responsible AI use, resilient logistics, and region-specific compliance practices will be better positioned to support increasingly complex testing programs.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Enzyme-Linked Immunosorbent Assay Service Market, by Assay Type
7.1. Introduction
7.2. Competitive
7.3. Direct
7.4. Indirect
7.5. Sandwich
8. Enzyme-Linked Immunosorbent Assay Service Market, by Detection Method
8.1. Introduction
8.2. Chemiluminescent
8.3. Colorimetric
8.4. Fluorescent
9. Enzyme-Linked Immunosorbent Assay Service Market, by Sample Type
9.1. Introduction
9.2. Plasma
9.3. Serum
9.4. Urine
10. Enzyme-Linked Immunosorbent Assay Service Market, by End User
10.1. Introduction
10.2. Academic And Research Institutes
10.3. Contract Research Organizations
10.4. Hospitals And Diagnostic Laboratories
10.5. Pharmaceutical And Biotechnology Companies
11. Enzyme-Linked Immunosorbent Assay Service Market, by Application
11.1. Introduction
11.2. Disease Diagnostics
11.3. Drug Discovery
11.4. Quality Control
11.5. Research Purposes
12. Enzyme-Linked Immunosorbent Assay Service Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Enzyme-Linked Immunosorbent Assay Service Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Enzyme-Linked Immunosorbent Assay Service Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Abbott Laboratories
16.2. Abcam Limited.
16.3. ACROBIOSYSTEMS INC.
16.4. Agilent Technologies, Inc.
16.5. ALPCO Diagnostics
16.6. Avioq, Inc
16.7. Aviva Systems Biology Corporation
16.8. Becton, Dickinson and Company
16.9. Bio-Rad Laboratories, Inc.
16.10. Cayman Chemical Company
16.11. Cell Signaling Technology, Inc.
16.12. CLOUD-CLONE CORP.
16.13. Creative Diagnostics
16.14. DH Life Sciences, LLC.
16.15. Elabscience Bionovation Inc.
16.16. F. Hoffmann-La Roche Ltd
16.17. Laboratory Corporation of America Holdings
16.18. LifeSpan BioSciences, Inc
16.19. Precision Medicine Group Holdings, Inc.
16.20. RayBiotech, Inc.
16.21. ROCKLAND IMMUNOCHEMICALS, INC.
16.22. Sigma-Aldrich Chemicals Private Limited
16.23. Sino Biological Inc.
16.24. Thermo Fisher Scientific Inc.
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Enzyme-Linked Immunosorbent Assay Service Market, Years Considered for the Study
FIGURE 2. Global Enzyme-Linked Immunosorbent Assay Service Market, Research Design
FIGURE 3. Global Enzyme-Linked Immunosorbent Assay Service Market, Research Framework
FIGURE 4. Global Enzyme-Linked Immunosorbent Assay Service Market, Data Triangulation
FIGURE 5. Global Enzyme-Linked Immunosorbent Assay Service Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Enzyme-Linked Immunosorbent Assay Service Market Size, by Assay Type, 2025 vs 2032 (%)
FIGURE 7. Global Enzyme-Linked Immunosorbent Assay Service Market Size, by Assay Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Enzyme-Linked Immunosorbent Assay Service Market Size, by Detection Method, 2025 vs 2032 (%)
FIGURE 9. Global Enzyme-Linked Immunosorbent Assay Service Market Size, by Detection Method, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Enzyme-Linked Immunosorbent Assay Service Market Size, by Sample Type, 2025 vs 2032 (%)
FIGURE 11. Global Enzyme-Linked Immunosorbent Assay Service Market Size, by Sample Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Enzyme-Linked Immunosorbent Assay Service Market Size, by End User, 2025 vs 2032 (%)
FIGURE 13. Global Enzyme-Linked Immunosorbent Assay Service Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Enzyme-Linked Immunosorbent Assay Service Market Size, by Application, 2025 vs 2032 (%)
FIGURE 15. Global Enzyme-Linked Immunosorbent Assay Service Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Enzyme-Linked Immunosorbent Assay Service Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Enzyme-Linked Immunosorbent Assay Service Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Enzyme-Linked Immunosorbent Assay Service Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Enzyme-Linked Immunosorbent Assay Service Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Enzyme-Linked Immunosorbent Assay Service Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Enzyme-Linked Immunosorbent Assay Service Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Enzyme-Linked Immunosorbent Assay Service Market Segmentation & Coverage
TABLE 2. Global Enzyme-Linked Immunosorbent Assay Service Market Size, 2017-2032 (USD Million)
TABLE 3. Global Enzyme-Linked Immunosorbent Assay Service Market Size, by Assay Type, 2017-2032 (USD Million)
TABLE 4. Global Competitive Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Competitive Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Competitive Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Direct Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Direct Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Direct Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Indirect Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Indirect Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Indirect Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Sandwich Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Sandwich Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Sandwich Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Enzyme-Linked Immunosorbent Assay Service Market Size, by Detection Method, 2017-2032 (USD Million)
TABLE 17. Global Chemiluminescent Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Chemiluminescent Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Chemiluminescent Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Colorimetric Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Colorimetric Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Colorimetric Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Fluorescent Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Fluorescent Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Fluorescent Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Enzyme-Linked Immunosorbent Assay Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 27. Global Plasma Market Size, by Region, 2017-2032 (USD Million)
TABLE 28. Global Plasma Market Size, by Group, 2017-2032 (USD Million)
TABLE 29. Global Plasma Market Size, by Country, 2017-2032 (USD Million)
TABLE 30. Global Serum Market Size, by Region, 2017-2032 (USD Million)
TABLE 31. Global Serum Market Size, by Group, 2017-2032 (USD Million)
TABLE 32. Global Serum Market Size, by Country, 2017-2032 (USD Million)
TABLE 33. Global Urine Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Urine Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Urine Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global Enzyme-Linked Immunosorbent Assay Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 37. Global Academic And Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Academic And Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Academic And Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Contract Research Organizations Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Contract Research Organizations Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Contract Research Organizations Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Hospitals And Diagnostic Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Hospitals And Diagnostic Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Hospitals And Diagnostic Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Pharmaceutical And Biotechnology Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Pharmaceutical And Biotechnology Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Pharmaceutical And Biotechnology Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Enzyme-Linked Immunosorbent Assay Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 50. Global Disease Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Disease Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Disease Diagnostics Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Drug Discovery Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Drug Discovery Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Drug Discovery Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Quality Control Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Quality Control Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Quality Control Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Research Purposes Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Research Purposes Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Research Purposes Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Enzyme-Linked Immunosorbent Assay Service Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Asia-Pacific Enzyme-Linked Immunosorbent Assay Service Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Asia-Pacific Enzyme-Linked Immunosorbent Assay Service Market Size, by Assay Type, 2017-2032 (USD Million)
TABLE 65. Asia-Pacific Enzyme-Linked Immunosorbent Assay Service Market Size, by Detection Method, 2017-2032 (USD Million)
TABLE 66. Asia-Pacific Enzyme-Linked Immunosorbent Assay Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 67. Asia-Pacific Enzyme-Linked Immunosorbent Assay Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 68. Asia-Pacific Enzyme-Linked Immunosorbent Assay Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 69. North America Enzyme-Linked Immunosorbent Assay Service Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. North America Enzyme-Linked Immunosorbent Assay Service Market Size, by Assay Type, 2017-2032 (USD Million)
TABLE 71. North America Enzyme-Linked Immunosorbent Assay Service Market Size, by Detection Method, 2017-2032 (USD Million)
TABLE 72. North America Enzyme-Linked Immunosorbent Assay Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 73. North America Enzyme-Linked Immunosorbent Assay Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 74. North America Enzyme-Linked Immunosorbent Assay Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 75. Latin America Enzyme-Linked Immunosorbent Assay Service Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Latin America Enzyme-Linked Immunosorbent Assay Service Market Size, by Assay Type, 2017-2032 (USD Million)
TABLE 77. Latin America Enzyme-Linked Immunosorbent Assay Service Market Size, by Detection Method, 2017-2032 (USD Million)
TABLE 78. Latin America Enzyme-Linked Immunosorbent Assay Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 79. Latin America Enzyme-Linked Immunosorbent Assay Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 80. Latin America Enzyme-Linked Immunosorbent Assay Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 81. Europe Enzyme-Linked Immunosorbent Assay Service Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. Europe Enzyme-Linked Immunosorbent Assay Service Market Size, by Assay Type, 2017-2032 (USD Million)
TABLE 83. Europe Enzyme-Linked Immunosorbent Assay Service Market Size, by Detection Method, 2017-2032 (USD Million)
TABLE 84. Europe Enzyme-Linked Immunosorbent Assay Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 85. Europe Enzyme-Linked Immunosorbent Assay Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 86. Europe Enzyme-Linked Immunosorbent Assay Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 87. Middle East Enzyme-Linked Immunosorbent Assay Service Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Middle East Enzyme-Linked Immunosorbent Assay Service Market Size, by Assay Type, 2017-2032 (USD Million)
TABLE 89. Middle East Enzyme-Linked Immunosorbent Assay Service Market Size, by Detection Method, 2017-2032 (USD Million)
TABLE 90. Middle East Enzyme-Linked Immunosorbent Assay Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 91. Middle East Enzyme-Linked Immunosorbent Assay Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 92. Middle East Enzyme-Linked Immunosorbent Assay Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 93. Africa Enzyme-Linked Immunosorbent Assay Service Market Size, by Region, 2017-2032 (USD Million)
TABLE 94. Africa Enzyme-Linked Immunosorbent Assay Service Market Size, by Assay Type, 2017-2032 (USD Million)
TABLE 95. Africa Enzyme-Linked Immunosorbent Assay Service Market Size, by Detection Method, 2017-2032 (USD Million)
TABLE 96. Africa Enzyme-Linked Immunosorbent Assay Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 97. Africa Enzyme-Linked Immunosorbent Assay Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 98. Africa Enzyme-Linked Immunosorbent Assay Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 99. Global Enzyme-Linked Immunosorbent Assay Service Market Size, by Group, 2017-2032 (USD Million)
TABLE 100. ASEAN Enzyme-Linked Immunosorbent Assay Service Market Size, by Group, 2017-2032 (USD Million)
TABLE 101. ASEAN Enzyme-Linked Immunosorbent Assay Service Market Size, by Assay Type, 2017-2032 (USD Million)
TABLE 102. ASEAN Enzyme-Linked Immunosorbent Assay Service Market Size, by Detection Method, 2017-2032 (USD Million)
TABLE 103. ASEAN Enzyme-Linked Immunosorbent Assay Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 104. ASEAN Enzyme-Linked Immunosorbent Assay Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 105. ASEAN Enzyme-Linked Immunosorbent Assay Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 106. GCC Enzyme-Linked Immunosorbent Assay Service Market Size, by Group, 2017-2032 (USD Million)
TABLE 107. GCC Enzyme-Linked Immunosorbent Assay Service Market Size, by Assay Type, 2017-2032 (USD Million)
TABLE 108. GCC Enzyme-Linked Immunosorbent Assay Service Market Size, by Detection Method, 2017-2032 (USD Million)
TABLE 109. GCC Enzyme-Linked Immunosorbent Assay Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 110. GCC Enzyme-Linked Immunosorbent Assay Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 111. GCC Enzyme-Linked Immunosorbent Assay Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 112. European Union Enzyme-Linked Immunosorbent Assay Service Market Size, by Group, 2017-2032 (USD Million)
TABLE 113. European Union Enzyme-Linked Immunosorbent Assay Service Market Size, by Assay Type, 2017-2032 (USD Million)
TABLE 114. European Union Enzyme-Linked Immunosorbent Assay Service Market Size, by Detection Method, 2017-2032 (USD Million)
TABLE 115. European Union Enzyme-Linked Immunosorbent Assay Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 116. European Union Enzyme-Linked Immunosorbent Assay Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 117. European Union Enzyme-Linked Immunosorbent Assay Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 118. BRICS Enzyme-Linked Immunosorbent Assay Service Market Size, by Group, 2017-2032 (USD Million)
TABLE 119. BRICS Enzyme-Linked Immunosorbent Assay Service Market Size, by Assay Type, 2017-2032 (USD Million)
TABLE 120. BRICS Enzyme-Linked Immunosorbent Assay Service Market Size, by Detection Method, 2017-2032 (USD Million)
TABLE 121. BRICS Enzyme-Linked Immunosorbent Assay Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 122. BRICS Enzyme-Linked Immunosorbent Assay Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 123. BRICS Enzyme-Linked Immunosorbent Assay Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 124. G7 Enzyme-Linked Immunosorbent Assay Service Market Size, by Group, 2017-2032 (USD Million)
TABLE 125. G7 Enzyme-Linked Immunosorbent Assay Service Market Size, by Assay Type, 2017-2032 (USD Million)
TABLE 126. G7 Enzyme-Linked Immunosorbent Assay Service Market Size, by Detection Method, 2017-2032 (USD Million)
TABLE 127. G7 Enzyme-Linked Immunosorbent Assay Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 128. G7 Enzyme-Linked Immunosorbent Assay Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 129. G7 Enzyme-Linked Immunosorbent Assay Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 130. NATO Enzyme-Linked Immunosorbent Assay Service Market Size, by Group, 2017-2032 (USD Million)
TABLE 131. NATO Enzyme-Linked Immunosorbent Assay Service Market Size, by Assay Type, 2017-2032 (USD Million)
TABLE 132. NATO Enzyme-Linked Immunosorbent Assay Service Market Size, by Detection Method, 2017-2032 (USD Million)
TABLE 133. NATO Enzyme-Linked Immunosorbent Assay Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 134. NATO Enzyme-Linked Immunosorbent Assay Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 135. NATO Enzyme-Linked Immunosorbent Assay Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 136. Global Enzyme-Linked Immunosorbent Assay Service Market Size, by Country, 2017-2032 (USD Million)
TABLE 137. United States Enzyme-Linked Immunosorbent Assay Service Market Size, 2017-2032 (USD Million)
TABLE 138. United States Enzyme-Linked Immunosorbent Assay Service Market Size, by Assay Type, 2017-2032 (USD Million)
TABLE 139. United States Enzyme-Linked Immunosorbent Assay Service Market Size, by Detection Method, 2017-2032 (USD Million)
TABLE 140. United States Enzyme-Linked Immunosorbent Assay Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 141. United States Enzyme-Linked Immunosorbent Assay Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 142. United States Enzyme-Linked Immunosorbent Assay Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 143. Canada Enzyme-Linked Immunosorbent Assay Service Market Size, 2017-2032 (USD Million)
TABLE 144. Canada Enzyme-Linked Immunosorbent Assay Service Market Size, by Assay Type, 2017-2032 (USD Million)
TABLE 145. Canada Enzyme-Linked Immunosorbent Assay Service Market Size, by Detection Method, 2017-2032 (USD Million)
TABLE 146. Canada Enzyme-Linked Immunosorbent Assay Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 147. Canada Enzyme-Linked Immunosorbent Assay Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 148. Canada Enzyme-Linked Immunosorbent Assay Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 149. Mexico Enzyme-Linked Immunosorbent Assay Service Market Size, 2017-2032 (USD Million)
TABLE 150. Mexico Enzyme-Linked Immunosorbent Assay Service Market Size, by Assay Type, 2017-2032 (USD Million)
TABLE 151. Mexico Enzyme-Linked Immunosorbent Assay Service Market Size, by Detection Method, 2017-2032 (USD Million)
TABLE 152. Mexico Enzyme-Linked Immunosorbent Assay Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 153. Mexico Enzyme-Linked Immunosorbent Assay Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 154. Mexico Enzyme-Linked Immunosorbent Assay Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 155. Brazil Enzyme-Linked Immunosorbent Assay Service Market Size, 2017-2032 (USD Million)
TABLE 156. Brazil Enzyme-Linked Immunosorbent Assay Service Market Size, by Assay Type, 2017-2032 (USD Million)
TABLE 157. Brazil Enzyme-Linked Immunosorbent Assay Service Market Size, by Detection Method, 2017-2032 (USD Million)
TABLE 158. Brazil Enzyme-Linked Immunosorbent Assay Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 159. Brazil Enzyme-Linked Immunosorbent Assay Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 160. Brazil Enzyme-Linked Immunosorbent Assay Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 161. United Kingdom Enzyme-Linked Immunosorbent Assay Service Market Size, 2017-2032 (USD Million)
TABLE 162. United Kingdom Enzyme-Linked Immunosorbent Assay Service Market Size, by Assay Type, 2017-2032 (USD Million)
TABLE 163. United Kingdom Enzyme-Linked Immunosorbent Assay Service Market Size, by Detection Method, 2017-2032 (USD Million)
TABLE 164. United Kingdom Enzyme-Linked Immunosorbent Assay Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 165. United Kingdom Enzyme-Linked Immunosorbent Assay Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 166. United Kingdom Enzyme-Linked Immunosorbent Assay Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 167. Germany Enzyme-Linked Immunosorbent Assay Service Market Size, 2017-2032 (USD Million)
TABLE 168. Germany Enzyme-Linked Immunosorbent Assay Service Market Size, by Assay Type, 2017-2032 (USD Million)
TABLE 169. Germany Enzyme-Linked Immunosorbent Assay Service Market Size, by Detection Method, 2017-2032 (USD Million)
TABLE 170. Germany Enzyme-Linked Immunosorbent Assay Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 171. Germany Enzyme-Linked Immunosorbent Assay Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 172. Germany Enzyme-Linked Immunosorbent Assay Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 173. France Enzyme-Linked Immunosorbent Assay Service Market Size, 2017-2032 (USD Million)
TABLE 174. France Enzyme-Linked Immunosorbent Assay Service Market Size, by Assay Type, 2017-2032 (USD Million)
TABLE 175. France Enzyme-Linked Immunosorbent Assay Service Market Size, by Detection Method, 2017-2032 (USD Million)
TABLE 176. France Enzyme-Linked Immunosorbent Assay Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 177. France Enzyme-Linked Immunosorbent Assay Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 178. France Enzyme-Linked Immunosorbent Assay Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 179. Russia Enzyme-Linked Immunosorbent Assay Service Market Size, 2017-2032 (USD Million)
TABLE 180. Russia Enzyme-Linked Immunosorbent Assay Service Market Size, by Assay Type, 2017-2032 (USD Million)
TABLE 181. Russia Enzyme-Linked Immunosorbent Assay Service Market Size, by Detection Method, 2017-2032 (USD Million)
TABLE 182. Russia Enzyme-Linked Immunosorbent Assay Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 183. Russia Enzyme-Linked Immunosorbent Assay Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 184. Russia Enzyme-Linked Immunosorbent Assay Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 185. Italy Enzyme-Linked Immunosorbent Assay Service Market Size, 2017-2032 (USD Million)
TABLE 186. Italy Enzyme-Linked Immunosorbent Assay Service Market Size, by Assay Type, 2017-2032 (USD Million)
TABLE 187. Italy Enzyme-Linked Immunosorbent Assay Service Market Size, by Detection Method, 2017-2032 (USD Million)
TABLE 188. Italy Enzyme-Linked Immunosorbent Assay Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 189. Italy Enzyme-Linked Immunosorbent Assay Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 190. Italy Enzyme-Linked Immunosorbent Assay Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 191. Spain Enzyme-Linked Immunosorbent Assay Service Market Size, 2017-2032 (USD Million)
TABLE 192. Spain Enzyme-Linked Immunosorbent Assay Service Market Size, by Assay Type, 2017-2032 (USD Million)
TABLE 193. Spain Enzyme-Linked Immunosorbent Assay Service Market Size, by Detection Method, 2017-2032 (USD Million)
TABLE 194. Spain Enzyme-Linked Immunosorbent Assay Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 195. Spain Enzyme-Linked Immunosorbent Assay Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 196. Spain Enzyme-Linked Immunosorbent Assay Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 197. China Enzyme-Linked Immunosorbent Assay Service Market Size, 2017-2032 (USD Million)
TABLE 198. China Enzyme-Linked Immunosorbent Assay Service Market Size, by Assay Type, 2017-2032 (USD Million)
TABLE 199. China Enzyme-Linked Immunosorbent Assay Service Market Size, by Detection Method, 2017-2032 (USD Million)
TABLE 200. China Enzyme-Linked Immunosorbent Assay Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 201. China Enzyme-Linked Immunosorbent Assay Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 202. China Enzyme-Linked Immunosorbent Assay Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 203. India Enzyme-Linked Immunosorbent Assay Service Market Size, 2017-2032 (USD Million)
TABLE 204. India Enzyme-Linked Immunosorbent Assay Service Market Size, by Assay Type, 2017-2032 (USD Million)
TABLE 205. India Enzyme-Linked Immunosorbent Assay Service Market Size, by Detection Method, 2017-2032 (USD Million)
TABLE 206. India Enzyme-Linked Immunosorbent Assay Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 207. India Enzyme-Linked Immunosorbent Assay Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 208. India Enzyme-Linked Immunosorbent Assay Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 209. Japan Enzyme-Linked Immunosorbent Assay Service Market Size, 2017-2032 (USD Million)
TABLE 210. Japan Enzyme-Linked Immunosorbent Assay Service Market Size, by Assay Type, 2017-2032 (USD Million)
TABLE 211. Japan Enzyme-Linked Immunosorbent Assay Service Market Size, by Detection Method, 2017-2032 (USD Million)
TABLE 212. Japan Enzyme-Linked Immunosorbent Assay Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 213. Japan Enzyme-Linked Immunosorbent Assay Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 214. Japan Enzyme-Linked Immunosorbent Assay Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 215. Australia Enzyme-Linked Immunosorbent Assay Service Market Size, 2017-2032 (USD Million)
TABLE 216. Australia Enzyme-Linked Immunosorbent Assay Service Market Size, by Assay Type, 2017-2032 (USD Million)
TABLE 217. Australia Enzyme-Linked Immunosorbent Assay Service Market Size, by Detection Method, 2017-2032 (USD Million)
TABLE 218. Australia Enzyme-Linked Immunosorbent Assay Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 219. Australia Enzyme-Linked Immunosorbent Assay Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 220. Australia Enzyme-Linked Immunosorbent Assay Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 221. South Korea Enzyme-Linked Immunosorbent Assay Service Market Size, 2017-2032 (USD Million)
TABLE 222. South Korea Enzyme-Linked Immunosorbent Assay Service Market Size, by Assay Type, 2017-2032 (USD Million)
TABLE 223. South Korea Enzyme-Linked Immunosorbent Assay Service Market Size, by Detection Method, 2017-2032 (USD Million)
TABLE 224. South Korea Enzyme-Linked Immunosorbent Assay Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 225. South Korea Enzyme-Linked Immunosorbent Assay Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 226. South Korea Enzyme-Linked Immunosorbent Assay Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 227. Global Enzyme-Linked Immunosorbent Assay Service Market Share, by Key Player, 2025
TABLE 228. Global Enzyme-Linked Immunosorbent Assay Service Market, Key Experts

Companies Mentioned

  • Abbott Laboratories
  • Abcam Limited.
  • ACROBIOSYSTEMS INC.
  • Agilent Technologies, Inc.
  • ALPCO Diagnostics
  • Avioq, Inc
  • Aviva Systems Biology Corporation
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Cayman Chemical Company
  • Cell Signaling Technology, Inc.
  • CLOUD-CLONE CORP.
  • Creative Diagnostics
  • DH Life Sciences, LLC.
  • Elabscience Bionovation Inc.
  • F. Hoffmann-La Roche Ltd
  • Laboratory Corporation of America Holdings
  • LifeSpan BioSciences, Inc
  • Precision Medicine Group Holdings, Inc.
  • RayBiotech, Inc.
  • ROCKLAND IMMUNOCHEMICALS, INC.
  • Sigma-Aldrich Chemicals Private Limited
  • Sino Biological Inc.
  • Thermo Fisher Scientific Inc.

Related Topics

Related Reports

Enzyme-linked Immunosorbent Assay Testing Market - Global Forecast 2026-2032 - Product Image

Enzyme-linked Immunosorbent Assay Testing Market - Global Forecast 2026-2032

  • Report
  • 187 Pages
  • Global
From
Enzyme-linked Immunosorbent Assay (Elisa) Testing - Global Strategic Business Report - Product Image

Enzyme-linked Immunosorbent Assay (Elisa) Testing - Global Strategic Business Report

  • Report
  • 262 Pages
  • Global
From
Enzyme-Linked Immunosorbent Assay (ELISA) Analyzers Market Report 2026 - Product Image

Enzyme-Linked Immunosorbent Assay (ELISA) Analyzers Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Enzyme Linked Immunosorbent Assay Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Image

Enzyme Linked Immunosorbent Assay Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • 180 Pages
  • Global
From
Enzyme-Linked Immunosorbent Assay Testing Market Report 2026 - Product Image

Enzyme-Linked Immunosorbent Assay Testing Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.